{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-046170","form_type":"8-K","ticker":"TOVX","cik":"0000894158","company_name":"Theriva Biologics, Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.696268+00:00","generated_at":"2026-05-22T06:21:59.615364+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Theriva Biologics closes $7.5M public offering of common stock and warrants","bullets":["Gross proceeds of ~$7.5M from offering of 6.8M shares (or pre-funded warrants) and common warrants at $1.10/unit.","Offering includes 1.99M shares, 4.83M pre-funded warrants, and 6.82M common warrants exercisable at $1.10 for 5 years.","Proceeds primarily for working capital, R&D, and manufacturing scale-up; no acquisition commitments.","Post-closing shares outstanding: 4,773,358 (excluding warrants).","A.G.P./Alliance Global Partners acted as placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-046170","json":"https://secwatch.observer/filing/0001104659-25-046170.json","markdown":"https://secwatch.observer/filing/0001104659-25-046170.md","text":"https://secwatch.observer/filing/0001104659-25-046170.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/894158/000110465925046170/0001104659-25-046170-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/894158/000110465925046170/tm2514447d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T06:21:59.615364+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}